Prefilled Syringe for Arthritis Treatment Market

The global prefilled syringe for arthritis treatment market is being driven by the technical developments in auto-injectors and increasing use of prefilled syringes. Because of the benefits they provide, such as greater patient safety and simplicity for healthcare practitioners in dosage preparation and delivery, prefilled syringes are quickly overtaking conventional syringe-vial combinations.

These syringes make chronic conditions like rheumatoid arthritis and diabetes easier to treat, which is predicted to increase the use of pen injectors and auto-injectors. Prefilled syringes refer to medicine storage devices that are sold to patients for the delivery of medication for a specified therapy. These syringes can be utilized for emergency therapy and can offer single-dose medication delivery. The spike in the number of instances of arthritis throughout the world is likely to drive the global prefilled syringe for arthritis treatment market in the years to come. As per a research conducted by Aarhus University in Denmark, the cost of producing one prefilled syringe is expected to be between US$9 and US$10. When it comes to selling prefilled syringes to customers, producers can make a huge profit (well over 20%), which is likely to work in favor of the global prefilled syringe for arthritis treatment market.

Prefilled syringes are devices that are used to store medicines and are sold to patients for the administration of drugs for specific a treatment. They provide single dose administration of drugs and can be used for emergency treatment.

The global prefilled syringe for arthritis treatment market is primarily driven due to a rise in the number of cases of arthritis worldwide. According to a study by the Aaarhus University, Denmark, the approximate manufacturing cost of one prefilled syringe is estimated to be around US$ 9 to US$10. Manufacturers can make a significant profit (more than 20%) when they sell prefilled syringes to end-users. Other advantages of these syringes include less overfill of drugs and lower risk of medication errors.

However, the growth of the global prefilled syringe for arthritis treatment market is restrained by the risk of contamination of disease and stringent regulatory landscape and intellectual property rights laws. Nevertheless, mergers and acquisitions among key players, increase in R&D investment by major companies, and technological progress are estimated to provide the global prefilled syringe for arthritis treatment market an opportunity for expansion during the forecast period.

In terms of product, the global prefilled syringe for arthritis treatment market can be segmented into glass prefilled syringe and plastic prefilled syringe. Based on design, the global prefilled syringe for arthritis treatment market can be classified into single chamber prefilled syringe, dual chamber prefilled syringe, and customized prefilled syringe. In terms of therapeutic category, the global prefilled syringe for arthritis treatment market can be categorized into rheumatoid arthritis, osteoarthritis, psoriatic arthritis and others. Based on end-user, the global prefilled syringe for arthritis treatment market can be divided into hospitals, clinics, and home care settings.

In terms of region, the global prefilled syringe for arthritis treatment market can be classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to the Centers for Disease Prevention and Control (CDC), around 22.7% of U.S. adults (about 54.4 million) suffered from some form of arthritis in 2014, whereas the prevalence of arthritis is much higher in females as compared to that in males. On the basis of information published by the Statcan, Canada, the prevalence of arthritis was estimated to 16.5% of the adult population (4.8 million adults) in 2014 in Canada. Moreover, over 120 million people in Europe are affected by some forms of rheumatic and musculoskeletal diseases. Almost one person from every family suffers from rheumatic and musculoskeletal disease in the region. The prefilled syringe for arthritis treatment market in North America and Europe held a major market share in 2017, owing to the significant prevalence of arthritis in North America and Europe, high rate of diagnosis and treatment of arthritis, robust health care infrastructure, and the presence of major players in the regions.

The prefilled syringe for arthritis treatment market in Asia Pacific is anticipated to expand at a rapid CAGR during the forecast period, due to an increase in the geriatric population, rise in cases of arthritis in the region, developing health care infrastructure, technological advancements, and participation of domestic players. The market in Latin America and Middle East & Africa is likely to be hampered by weak health care infrastructure and lower diagnosis and treatment rates of arthritis.

Major players acting in the global prefilled syringe for arthritis treatment market are AbbVie GK, Sanofi and Regeneron Pharmaceuticals, Inc, Bristol-Myers Squibb Company, UCB Group of Companies, Amgen Inc., Janssen Biotech, Inc, Roche, Eli Lilly and Company, and others.

This intelligence report by TMR is the outcome of intense study and rigorous assessment of various dynamics shaping the growth of the market. TMR nurtures a close-knit team of analysts, strategists, and industry experts who offer clients tools, methodologies, and frameworks to make smarter decisions. Our objective, insights, and actionable analytics provide CXOs and executives to advance their mission-critical priorities with confidence.

The scrutiny of the various forces impacting the dynamics of the market, and key and associated industries, guides enterprises in understanding various consumer propositions. Our clients leverage these insights and perspectives to enhance customer experience in the fast-paced business environment.

All our insights and perspectives are broadly based on 4 Pillars or Stages: ASBC-S, which offer an elaborate and customizable framework for the success of an organization. The essence and the roles of these in organizational successes are highlighted below:

  • Agenda for CXOs: TMR, through the study, sets the tone for agendas that are pertinent to CEOs, CFOs, CIOs, and other CXO executives of businesses operating in the market. The perspectives help our clients to bridge the gap between agenda and action plan. TMR strives to offer guidance to CXOs to undertake mission-critical activities empowered by various business analysis tools, and boost the performance of the organizations. The perspectives guide you to decide on your own marketing mix that align well with the policies, visions, and mission.
  • Strategic Frameworks: The study offers how organizations are setting both short-term and long-term strategic plans. Our team of experts collaborate and communicate with you to understand these to make your organizations sustainable and resilient during tough times. The insights help them decide sustainable competitive advantage for each business units.
  • Benchmarking for Deciding Target Markets and Brand Positioning: The assessments in the study provides a scrutiny of marketing channels and marketing mix. Our various teams work synergistically with you to help identify your actual and potential direct, indirect, and budget competition areas. Additionally, the study helps you decide most effective budgets for various processes and promotional activities. Furthermore, the study guides you to set benchmarks for integrating people and processes with the 4Ps of marketing. Eventually, this will empower you to find out unique propositioning strategies and niches.
  • Business Composability for Sustainability (C-S): Constant strategy planning for sustainability characterizing our C-S framework in the report has become more relevant than before in the face of disruptions caused by pandemics, recessions, boom and bust cycles, and changing geopolitical scenario. The TMR study offers a high level of customization to help you achieve business composability. Composable enterprises are increasingly gaining the attention of CXOs in order to help them combat market volatility. Our analysts and industry experts help you wade through such uncertainties and guide you to become a smart sustainable business in entirety.

The study presents scrutiny of region-specific consumer and technology trends, including the most recent industry dynamics. These broadly cover but not limited to

  • North America, South America, and the Americas
  • Asia Pacific and Japan
  • Europe
  • Latin America
  • Middle East and Africa

The study offers data-driven insights and guidance of several aspects. Some of the more notable questions are:

  • What are the major recent trends that can influence the product life cycle and the RoI?
  • Which regulatory trends shape corporate-level, business-level, and functional-level strategies?
  • Which micromarketing initiatives of leading players will bring in investments?
  • What can be the best framework and tools for PESTLE analysis?
  • Which regions will witness rise in new opportunities?
  • Which are the game-changing technologies being used to capture new revenue streams in the near future?
  • Which operational and tactical frameworks are being adopted by various players in gaining customer loyalty?
  • What is the current and expected intensity of competition the market in the near future?

Disclaimer: This market research study is an ongoing effort and extreme care has been taken to maintain the highest levels of accuracy at all stages. However, in the light of the rapidly evolving business dynamics, some region-specific or other segment-specific changes may take time to be part of the study.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Prefilled Syringe For Arthritis Treatment Market